Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Condition(s):Hormone-Resistant Prostate Cancer; Metastatic Prostate Carcinoma; Recurrent Prostate Carcinoma; Stage IV Prostate AdenocarcinomaLast Updated:May 14, 2021Completed